510(k) K201181
K201181 is an FDA 510(k) premarket notification submitted by ABBOTT MEDICAL for the device "EnSite Velocity Cardiac Mapping System, EnSite Precision Cardiac Mapping System". The FDA issued a decision of Substantially Equivalent on Jun 26, 2020. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. ABBOTT MEDICAL has 59 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 26, 2020
- Date Received
- Apr 30, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computer, Diagnostic, Programmable
- Device Class
- Class II
- Regulation Number
- 870.1425
- Review Panel
- CV
- Submission Type
- 510(k)